Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer.

Molecular medicine (Cambridge, Mass.) - 3 Jul 2021

Qvick Alvida, Stenmark Bianca, Carlsson Jessica, Isaksson Johan, Karlsson Christina, Helenius Gisela

Abstract excerpt

BACKGROUND: The aim of this study was to investigate the clinical value of liquid biopsy as a primary source for variant analysis in lung cancer. In addition, we sought to characterize liquid biopsy variants and to correlate mutational load to clinical data. METHODS: Circulating cell-free DNA was extracted from plasma from patients with lung cancer (n = 60) and controls with benign lung disease (n = 16). Variant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell-Free Nucleic Acids
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Liquid Biopsy

Share to Neoplasm Grading

Share to Neoplasm Staging

Share to Reproducibility of Results

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 34217228
DOI: 10.1186/s10020-021-00331-1
PMCID: PMC8254966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer.PMID 34217228Read ↗

Liquid Biopsy as an Option for Predictive Testing and Prognosis in Patients with Lung CancerSemantic proximity Read ↗

Liquid biopsy and its role in an advanced clinical trial for lung cancer.Semantic proximity Read ↗

Liquid biopsy tracking of lung tumor evolutions over timeSemantic proximity Read ↗

Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer.Semantic proximity Read ↗

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Semantic proximity Read ↗

Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patientsSemantic proximity Read ↗

Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.Semantic proximity Read ↗

The evolving role of liquid biopsy in lung cancer.Semantic proximity Read ↗

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.Semantic proximity Read ↗

Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients.Semantic proximity Read ↗

Blood-based circulating tumor DNA mutations as a diagnostic and prognostic biomarker for lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.